Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | BIOXCEL THERAPEUTICS INC BTAI | FMR LLC | 262,715 14.999% | 399 (+0.15%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | BIOXCEL THERAPEUTICS INC BTAI | BlackRock Inc. BLK | 91,433 5.200% | 91,433 (New Position) | Filing History |
| 2023-02-02 4:45 pm Purchase | 2023-01-23 | 13G | BIOXCEL THERAPEUTICS INC BTAI | ADAGE CAPITAL PARTNERS GP L.L.C. | 96,787 5.530% | 96,787 (New Position) | Filing History |
| 2022-02-14 4:57 pm Sale | 2021-12-31 | 13G | BIOXCEL THERAPEUTICS INC BTAI | BioXcel Holdings Inc. | 582,378 32.400% | -19,810 (-3.29%) | Filing History |
| 2022-02-14 4:02 pm Purchase | 2022-02-14 | 13G | BIOXCEL THERAPEUTICS INC BTAI | ALLIANCEBERNSTEIN L.P. | 93,098 5.400% | 93,098 (New Position) | Filing History |
| 2022-02-09 12:01 pm Sale | 2021-12-31 | 13G | BIOXCEL THERAPEUTICS INC BTAI | STATE STREET CORP STT | 84,068 4.810% | -20,557 (-19.65%) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | BIOXCEL THERAPEUTICS INC BTAI | FMR LLC | 262,316 14.999% | 67,640 (+34.74%) | Filing History |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | BIOXCEL THERAPEUTICS INC BTAI | FMR LLC | 194,676 11.021% | 69,552 (+55.59%) | Filing History |